ポリオワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Polio Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16301 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ポリオワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のポリオワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のポリオワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ポリオワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） 用途別セグメントは次のように区分されます。 ・パブリック、個人用 世界のポリオワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ポリオワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なポリオワクチンメーカーの企業概要、2019年～2021年までのポリオワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なポリオワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ポリオワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのポリオワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのポリオワクチン市場予測を収録しています。 ・第12、13、14章では、ポリオワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） ・用途別分析2016年-2026年：パブリック、個人用 ・ポリオワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポリオワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポリオワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポリオワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポリオワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Polio Vaccine size is estimated to be XX million in 2021 from USD 688.9 million in 2020, with a change of XX% between 2020 and 2021. The global Polio Vaccine market size is expected to grow at a CAGR of 4.0% for the next five years.

Market segmentation
Polio Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Market segment by Application can be divided into
Public
Private

The key market players for global Polio Vaccine market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales, revenue and global market share of Polio Vaccine from 2019 to 2021.
Chapter 3, the Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Polio Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polio Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Polio Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size & Forecast
1.4.1 Global Polio Vaccine Sales in Value (2016-2026))
1.4.2 Global Polio Vaccine Sales in Volume (2016-2026)
1.4.3 Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
1.5 Global Polio Vaccine Production Capacity Analysis
1.5.1 Global Polio Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Polio Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Polio Vaccine Market Drivers
1.6.2 Polio Vaccine Market Restraints
1.6.3 Polio Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Polio Vaccine Product and Services
2.1.4 Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Polio Vaccine Product and Services
2.2.4 GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Polio Vaccine Product and Services
2.3.4 Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Polio Vaccine Product and Services
2.4.4 Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Polio Vaccine Product and Services
2.5.4 Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Polio Vaccine Product and Services
2.6.4 IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Polio Vaccine Product and Services
2.8.4 Bio-Med Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Polio Vaccine Sales by Manufacturer
3.1 Global Polio Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Polio Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Polio Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Polio Vaccine Manufacturer Market Share
3.4.2 Top 6 Polio Vaccine Manufacturer Market Share
3.5 Global Polio Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Polio Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Polio Vaccine Market Size by Region
4.1.1 Global Polio Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Polio Vaccine Revenue by Region (2016-2026)
4.2 North America Polio Vaccine Revenue (2016-2026)
4.3 Europe Polio Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Polio Vaccine Revenue (2016-2026)
4.5 South America Polio Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Polio Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Polio Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Polio Vaccine Revenue by Type (2016-2026)
5.3 Global Polio Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Polio Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Polio Vaccine Revenue by Application (2016-2026)
6.3 Global Polio Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Polio Vaccine Sales by Type (2016-2026)
7.2 North America Polio Vaccine Sales by Application (2016-2026)
7.3 North America Polio Vaccine Market Size by Country
7.3.1 North America Polio Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Polio Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Polio Vaccine Sales by Type (2016-2026)
8.2 Europe Polio Vaccine Sales by Application (2016-2026)
8.3 Europe Polio Vaccine Market Size by Country
8.3.1 Europe Polio Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Polio Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Polio Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Polio Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Polio Vaccine Market Size by Region
9.3.1 Asia-Pacific Polio Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Polio Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Polio Vaccine Sales by Type (2016-2026)
10.2 South America Polio Vaccine Sales by Application (2016-2026)
10.3 South America Polio Vaccine Market Size by Country
10.3.1 South America Polio Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Polio Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Polio Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Polio Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Polio Vaccine Market Size by Country
11.3.1 Middle East & Africa Polio Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Polio Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Polio Vaccine Typical Distributors
12.3 Polio Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Polio Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Polio Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Polio Vaccine Product and Services
Table 6. Sanofi Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Polio Vaccine Product and Services
Table 10. GSK Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Polio Vaccine Product and Services
Table 14. Bibcol Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Polio Vaccine Product and Services
Table 18. Serum Institute Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Polio Vaccine Product and Services
Table 22. Tiantan Biological Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Polio Vaccine Product and Services
Table 26. IMBCA Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 30. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Polio Vaccine Product and Services
Table 34. Bio-Med Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Polio Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
Table 40. Global Polio Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Polio Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 43. Head Office and Polio Vaccine Production Site of Key Manufacturer
Table 44. Polio Vaccine New Entrant and Capacity Expansion Plans
Table 45. Polio Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Polio Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 47. Global Polio Vaccine Sales by Region (2021-2026) & (M Doses)
Table 48. Global Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 51. Global Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 52. Global Polio Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Polio Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Polio Vaccine Price by Type (2016-2021e) & (USD/K Doses)
Table 55. Global Polio Vaccine Price by Type (2021-2026) & (USD/K Doses)
Table 56. Global Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 57. Global Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 58. Global Polio Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Polio Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Polio Vaccine Price by Application (2016-2021e) & (USD/K Doses)
Table 61. Global Polio Vaccine Price by Application (2021-2026) & (USD/K Doses)
Table 62. North America Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 63. North America Polio Vaccine Sales by Country (2021-2026) & (M Doses)
Table 64. North America Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 67. North America Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 68. North America Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 69. North America Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 70. Europe Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 71. Europe Polio Vaccine Sales by Country (2021-2026) & (M Doses)
Table 72. Europe Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 75. Europe Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 76. Europe Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 77. Europe Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 78. Asia-Pacific Polio Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 79. Asia-Pacific Polio Vaccine Sales by Region (2021-2026) & (M Doses)
Table 80. Asia-Pacific Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 83. Asia-Pacific Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 84. Asia-Pacific Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 85. Asia-Pacific Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 86. South America Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 87. South America Polio Vaccine Sales by Country (2021-2026) & (M Doses)
Table 88. South America Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 91. South America Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 92. South America Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 93. South America Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 94. Middle East & Africa Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 95. Middle East & Africa Polio Vaccine Sales by Country (2021-2026) & (M Doses)
Table 96. Middle East & Africa Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 99. Middle East & Africa Polio Vaccine Sales by Type (2021-2026) & (M Doses)
Table 100. Middle East & Africa Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 101. Middle East & Africa Polio Vaccine Sales by Application (2021-2026) & (M Doses)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Polio Vaccine Typical Distributors
Table 105. Polio Vaccine Typical Customers
List of Figures
Figure 1. Polio Vaccine Picture
Figure 2. Global Polio Vaccine Sales Market Share by Type in 2020
Figure 3. Inactivated Polio Vaccine (IPV)
Figure 4. Oral Polio Vaccine (OPV)
Figure 5. Global Polio Vaccine Sales Market Share by Application in 2020
Figure 6. Public
Figure 7. Private
Figure 8. Global Polio Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 9. Global Polio Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Polio Vaccine Sales (2016-2026) & (M Doses)
Figure 11. Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
Figure 12. Global Polio Vaccine Production Capacity (2016-2026) & (M Doses)
Figure 13. Global Polio Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Polio Vaccine Market Drivers
Figure 15. Polio Vaccine Market Restraints
Figure 16. Polio Vaccine Market Trends
Figure 17. Global Polio Vaccine Sales Market Share by Manufacturer in 2020
Figure 18. Global Polio Vaccine Revenue Market Share by Manufacturer in 2020
Figure 19. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Polio Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Polio Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Polio Vaccine Sales Market Share by Region (2016-2026)
Figure 23. Global Polio Vaccine Revenue Market Share by Region (2016-2026)
Figure 24. North America Polio Vaccine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Polio Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Polio Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. South America Polio Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Polio Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Global Polio Vaccine Sales Market Share by Type (2016-2026)
Figure 30. Global Polio Vaccine Revenue Market Share by Type (2016-2026)
Figure 31. Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
Figure 32. Global Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 33. Global Polio Vaccine Revenue Market Share by Application (2016-2026)
Figure 34. Global Polio Vaccine Price by Application (2016-2026) & (USD/K Doses)
Figure 35. North America Polio Vaccine Sales Market Share by Type (2016-2026)
Figure 36. North America Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 37. North America Polio Vaccine Sales Market Share by Country (2016-2026)
Figure 38. North America Polio Vaccine Revenue Market Share by Country (2016-2026)
Figure 39. United States Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Polio Vaccine Sales Market Share by Type (2016-2026)
Figure 43. Europe Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 44. Europe Polio Vaccine Sales Market Share by Country (2016-2026)
Figure 45. Europe Polio Vaccine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Polio Vaccine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Polio Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Polio Vaccine Revenue Market Share by Region (2016-2026)
Figure 55. China Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Polio Vaccine Sales Market Share by Type (2016-2026)
Figure 62. South America Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 63. South America Polio Vaccine Sales Market Share by Country (2016-2026)
Figure 64. South America Polio Vaccine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Polio Vaccine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Polio Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Polio Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---